Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

NEXT STORY
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
PREV STORY
$74 Billion Pain Management Drugs Global Market to 2026 – by Drug Class, Indication, Distribution Channel and Region
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chi-Med Presents Further Fruquintinib FRESCO Trial Data at ASCO 2018 Annual Meeting

– Chi-Med makes additional FRESCO presentations at ASCO 2018, following oral presentation at ASCO ...

author_avatar
NASDAQ Market News

Incysus Announces Appointment of Joy Bessenger as Senior Vice President, Finance and Strategy

NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc., a biopharmaceutical company ...

author_avatar
NASDAQ Market News

LILLY MARKS NAMED BOARD CHAIR OF THE ASSOCIATION OF ACADEMIC HEALTH CENTERS

WASHINGTON, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Lilly Marks, vice President for health affairs ...

author_avatar
NASDAQ Market News